Related references
Note: Only part of the references are listed.Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1
L. Liu et al.
CANCER GENE THERAPY (2014)
TGF-β-Induced Upregulation of malat1 Promotes Bladder Cancer Metastasis by Associating with suz12
Yu Fan et al.
CLINICAL CANCER RESEARCH (2014)
Novel MSH6 Mutations in Treatment-Naive Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation
Stephanie A. Nguyen et al.
CLINICAL CANCER RESEARCH (2014)
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
Fan Lin et al.
CLINICAL CANCER RESEARCH (2014)
CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
Qiang Ding et al.
MOLECULAR CANCER (2014)
Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transition
J. Park et al.
ONCOGENE (2014)
Bone morphogenetic protein-7 (BMP-7) mediates ischemic preconditioning-induced ischemic tolerance via attenuating apoptosis in rat brain
Junhong Guan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
Beatrice Philip et al.
CARCINOGENESIS (2013)
Notch3 signaling gates cell cycle entry and limits neural stem cell amplification in the adult pallium
Alessandro Alunni et al.
DEVELOPMENT (2013)
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
Murielle Mimeault et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome
Shadi Lalezari et al.
NEURO-ONCOLOGY (2013)
Hypoxia Promotes Epithelial - Mesenchymal Transition of Hepatocellular Carcinoma Cells via Inducing GLIPR-2 Expression
Shao-guang Huang et al.
PLOS ONE (2013)
Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence
Fei Ye et al.
PLOS ONE (2013)
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
C. M. Tate et al.
CELL DEATH AND DIFFERENTIATION (2012)
Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
Caroline Happold et al.
JOURNAL OF NEUROCHEMISTRY (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer
Qiqun Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
L. Persano et al.
CELL DEATH & DISEASE (2012)
Ataxin-1 and Brother of ataxin-1 are components of the Notch signalling pathway
Xin Tong et al.
EMBO REPORTS (2011)
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Aya Kobayashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Dagmar Beier et al.
MOLECULAR CANCER (2011)
Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells
Yue Liu et al.
MOLECULAR CANCER RESEARCH (2011)
Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD133(+) Glioma Stem Cells to Temozolomide Therapy
Ilya V. Ulasov et al.
MOLECULAR MEDICINE (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
Imaging Bone Morphogenetic Protein 7 Induced Cell Cycle Arrest in Experimental Gliomas
Anke Klose et al.
NEOPLASIA (2011)
Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells
Sridhar Reddy Chirasani et al.
BRAIN (2010)
Sensitivity to temozolomide in brain tumor initiating cells
Michael D. Blough et al.
NEURO-ONCOLOGY (2010)
Extending Healthy Life Span-From Yeast to Humans
Luigi Fontana et al.
SCIENCE (2010)
Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate
Francesca Pistollato et al.
STEM CELLS (2010)
A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
M. Schaich et al.
ANNALS OF ONCOLOGY (2009)
TGF-β as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation
Satoshi Yamazaki et al.
BLOOD (2009)
A New Model for Prediction of Drug Distribution in Tumor and Normal Tissues: Pharmacokinetics of Temozolomide in Glioma Patients
Lula Rosso et al.
CANCER RESEARCH (2009)
PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
Anne-Marie Bleau et al.
CELL STEM CELL (2009)
Molecular properties of CD133+glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Qinghai Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Ulrich Wellner et al.
NATURE CELL BIOLOGY (2009)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
Neuroregenerative strategies in the brain: emerging significance of bone morphogenetic protein 7 (BMP7)
Mahmud Bani-Yaghoub et al.
BIOCHEMISTRY AND CELL BIOLOGY (2008)
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Dagmar Beier et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure
Yu-Hua Tseng et al.
NATURE (2008)
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Corinne E. Griguer et al.
PLOS ONE (2008)
CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain
Volkan Coskun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress
Tim J. Schulz et al.
CELL METABOLISM (2007)
Bone morphogenetic protein 7 in the development and treatment of bone Metastases from breast cancer
Jeroen T. Buijs et al.
CANCER RESEARCH (2007)
MGMT hypermethylation: A prognostic foe, a predictive friend
Filipe V. Jacinto et al.
DNA REPAIR (2007)
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo
Jeroen T. Buijs et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O-6-methylguanine
W. P. Roos et al.
ONCOGENE (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Primary glioblastomas express mesenchymal stem-like properties
Cho-Lea Tso et al.
MOLECULAR CANCER RESEARCH (2006)
Chemotherapy resistance of glioblastoma stem cells
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2006)
CD44 is a determinant of inflammatory bone loss
S Hayer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney
M Zeisberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide
ME Hegi et al.
CLINICAL CANCER RESEARCH (2004)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
CD44 modulates Smad1 activation in the BMP-7 signaling pathway
RS Peterson et al.
JOURNAL OF CELL BIOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
M Zeisberg et al.
NATURE MEDICINE (2003)
Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats
CF Chang et al.
STROKE (2003)
Extended longevity in mice lacking the insulin receptor in adipose tissue
M Blüher et al.
SCIENCE (2003)
Share Paper
